Patents by Inventor Anne R. Simoneau

Anne R. Simoneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of bladder and urinary tract cancers
    Patent number: 7326734
    Abstract: Compositions of matter and methods wherein chalcone and flavone derivatives are administered to human or veterinary patients for the treatment of bladder or urinary tract cancer. Compounds of the invention include 2?-hydroxy-4,4?,6?-trimethoxychalcone (Flavokawain A).
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: February 5, 2008
    Assignee: The Regents of the University of California
    Inventors: Xiolin Zi, Anne R. Simoneau
  • Treatment of bladder and urinary tract cancers
    Publication number: 20040259813
    Abstract: Compositions of matter and methods wherein chalcone and flavone derivatives are administered to human or veterinary patients for the treatment of bladder or urinary tract cancer. Compounds of the invention include 2′-hydroxy-4,4′,6′-trimethoxychalcone (Flavokawain A).
    Type: Application
    Filed: April 1, 2004
    Publication date: December 23, 2004
    Applicant: The Regents of the University of California
    Inventors: Xiolin Zi, Anne R. Simoneau
  • Alpha-difluoromethylornithine(DFMO) suppresses polyamine levels in the human prostate
    Publication number: 20040162353
    Abstract: The present invention concerns a method for treating and/or inhibiting prostate cancer in a patient comprising administering &agr;-difluoromethylornithine (DFMO) in an amount and duration sufficient to stabilize or reduce the amount of polyamine produced by the hyperplastic cells, wherein said polyamine is spermine, spermidine or a combination of spermine and spermidine. Methods of administration, dosing, and combinational therapies are described.
    Type: Application
    Filed: February 17, 2004
    Publication date: August 19, 2004
    Inventors: Frank L. Meyskens, Anne R. Simoneau, Eugene W. Gerner
  • Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostate
    Publication number: 20020137797
    Abstract: The present invention concerns a method for treating and/or inhibiting prostate cancer in a patient comprising administering &agr;-difluoromethylornithine (DFMO) in an amount and duration sufficient to stabilize or reduce the amount of polyamine produced by the hyperplastic cells, wherein said polyamine is spermine, spermidine or a combination of spermine and spermidine. Methods of administration, dosing, and combinational therapies are described.
    Type: Application
    Filed: August 24, 2001
    Publication date: September 26, 2002
    Inventors: Frank L. Meyskens, Anne R. Simoneau, Eugene W. Gerner